Long-term improvement of psoriasis patients’ adherence to topical drugs: testing a patient-supporting intervention delivered by healthcare professionals

BACKGROUND: Psoriasis affects 2–4% of the Western adult population and is a socio-economic burden for patients and society. Topical drugs are recommended as first-line treatment for mild-to-moderate psoriasis, but low adherence is a barrier to treatment success. Psoriasis patients require support, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Svendsen, Mathias Tiedemann, Feldman, Steven R., Möller, Sören, Kongstad, Line Planck, Andersen, Klaus Ejner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543428/
https://www.ncbi.nlm.nih.gov/pubmed/34696820
http://dx.doi.org/10.1186/s13063-021-05707-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543428/
https://www.ncbi.nlm.nih.gov/pubmed/34696820
http://dx.doi.org/10.1186/s13063-021-05707-6

Ejemplares similares